Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

@article{Grundy2005DiagnosisAM,
  title={Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement},
  author={Scott M. Grundy and James I. Cleeman and Stephen R Daniels and Karen A. Donato and Robert H. Eckel and Barry A. Franklin and David J. Gordon and Ronald M. Krauss and Peter J. Savage and Sidney C. Smith and John A. Spertus and Fernando Ferreira Costa},
  journal={Circulation},
  year={2005},
  volume={112},
  pages={2735-2752}
}
The metabolic syndrome has received increased attention in the past few years. This statement from the American Heart Association (AHA) and the National Heart, Lung, and Blood Institute (NHLBI) is intended to provide up-to-date guidance for professionals on the diagnosis and management of the metabolic syndrome in adults. The metabolic syndrome is a constellation of interrelated risk factors of metabolic origin— metabolic risk factors —that appear to directly promote the development of… Expand
Clinical benefits of the new definitions of the metabolic syndrome
TLDR
It is argued that, with the most recent criteria produced by the IDF and the AHA/NHLBL, the metabolic syndrome now has a valuable and easy-to-use clinical tool of great potential benefit to patients. Expand
A constellation of complications: the metabolic syndrome.
TLDR
The metabolic syndrome is a common cluster of risk factors for coronary heart disease and type 2 diabetes mellitus that includes obesity, elevated blood pressure, insulin resistance, and dyslipidemia that appears to be an important risk factor for atherogenic cardiovascular disease and diabetes. Expand
Linkage of Epidemiologic Evidence With the Clinical Aspects of Metabolic Syndrome
TLDR
In the presence of MetS, both singly and in combination, precede the development of ASCVD and IHD and individuals with pre-MetS must not be ignored as there is no apparent threshold in defining MetS. Expand
Metabolic Syndrome Pathophysiology and Clinical Presentation
TLDR
Lifestyle modification is the most important part of the management of people with the syndrome and medications—though none approved by the U.S. Food and Drug Administration—have been recommended by major medical societies when lifestyle modification is not enough or when it fails. Expand
Does a diagnosis of metabolic syndrome have value in clinical practice?
  • S. Grundy
  • Medicine
  • The American journal of clinical nutrition
  • 2006
TLDR
Treating the underlying causes of the metabolic syndrome does not rule out the management of individual risk factors, but it will add strength to the control of multiple risk factors. Expand
The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction.
TLDR
The metabolic syndrome has several properties that make it a useful construct, in conjunction with short-term risk prediction algorithms and sound clinical judgement, for the identification of those at high lifetime risk of CVD and diabetes. Expand
Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke among
TLDR
The metabolic syndrome based on NCEP-ATP III criteria predicted risks of isChemic heart disease, ischemic stroke and total cardiovascular disease more effectively, whereas that based on three other criteria predicted them less effectively. Expand
The metabolic syndrome in women
TLDR
Diagnostic and therapeutic issues that clinicians should consider when caring for women at risk for developing or diagnosed with the metabolic syndrome are provided. Expand
Metabolic syndrome under fire: weighing in on the truth.
TLDR
There is agreement that the risk factors of abdominal obesity, hypertension, elevated glucose and dyslipidemia commonly coexist in the same patient, and are important to identify when assessing an individual patient's risk, therefore, whether the 'syndrome' is a distinct clinical entity is not important. Expand
The relevance of the metabolic syndrome.
TLDR
The metabolic syndrome appears to have limited utility for the identification of individuals at increased risk of T2DM or CVD, and the diagnosis of the metabolic syndrome presents an opportunity to rationalise health services to deliver coordinated care to those with metabolic syndrome. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 180 REFERENCES
Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management
TLDR
The present report summarizes a second conference devoted to clinical management of the metabolic syndrome, which was sponsored by the AHA in partnership with the NHLBI and cosponsored by the American Diabetes Association (ADA). Expand
Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
TLDR
Although ATP III identified CVD as the primary clinical outcome of the metabolic syndrome, most people with this syndrome have insulin resistance, which confers increased risk for type 2 diabetes, when diabetes becomes clinically apparent, CVD risk rises sharply. Expand
Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey
TLDR
The results indicate a strong, consistent relationship of the metabolic syndrome with prevalent myocardial infarction and stroke. Expand
Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001.
TLDR
BMI and weight gain are important risk factors for the metabolic syndrome and regular physical activity may counter this risk, according to models adjusting simultaneously for all factors. Expand
Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease
TLDR
The results support the view of NCEP ATP III, that in CAD prevention, beyond lowering LDL‐cholesterol levels, interventions concerning the constituents of MS should be important. Expand
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
TLDR
The association between the metabolic syndrome and risk for chronic kidney disease and microalbuminuria in a large representative sample of U.S. adults who participated in the NHANES III was examined. Expand
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.
TLDR
The metabolic syndrome typically affects 20-30% of middle-aged adults in the U.S. and by any criteria, subjects with the metabolic syndrome are more insulin resistant and at increased predicted risk for CHD versus those without the syndrome. Expand
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
TLDR
Cardiovascular disease and all-cause mortality are increased in men with the metabolic syndrome, even in the absence of baseline CVD and diabetes, according to the Kuopio Ischaemic Heart Disease Risk Factor Study. Expand
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
TLDR
Among people with diabetes, the prevalence of metabolic syndrome was very high, and those with diabetes and metabolic syndrome had the highest prevalence of CHD, compared with those with both metabolic syndrome and diabetes, who had the lowest prevalence. Expand
Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?
TLDR
MS has primary predictive ability for CAD, carried primarily by high FG and low HDL, and secondary predictive ability of MS features for clinical outcomes, in the setting of established CAD, is carried by diabetes alone. Expand
...
1
2
3
4
5
...